Genotype Distributions in Top-level Soccer Players: A Role for ACE?

Abstract

We determined the genotype and allelic frequency of several genetic polymorphisms (ACE I/D, GDF-8 K153R [and also E164 K, P198A and I225 T] and AMPD1 C34 T) that are candidates to influence sports performance in a group of 54 male professional soccer players. Their results were compared with those of elite endurance male athletes (52 runners) and 123 sedentary, healthy men (controls). We found statistical significance for the ACE ID (χ² ₍₂₎=8.176, P=0.017) and II genotypes (χ² ₍₂₎=16.137, P<0.001) with a higher and lower frequency of ID (P=0.005) and II (P<0.001), respectively, in soccer players than in endurance runners. Statistical significance was also reached for AMPD1 (with a higher frequency of the CT genotype in soccer players than in runners [χ² ₍₂₎=7.538, P=0.006]) but not for GDF-8 K153R. Since the ACE II genotype is associated with improved potential for endurance performance but with decreased training gains in muscle mass and strength, these findings together with previous results [37] support the notion that elite soccer players tend to have a power/strength oriented genotype.

Key words

myostatin - GDF-8 - AMPD1 - genetics - sports - power - endurance

References

• 1 Ascensão A, Rebelo A, Oliveira E, Marques F, Pereira L, Magalhães J. Biochemical impact of a soccer match – analysis of oxidative stress and muscle damage markers throughout recovery.  Clin Biochem. 2008;  41 841-851
• 2 Bangsbo J. Energy demands in competitive soccer.  J Sports Sci. 1994;  12 S5-S12
• 3 Bangsbo J, Norregaard, L, Thorso F. Activity profile of competition soccer.  Can J Sports Sci. 1991;  16 110-116
• 4 Cam S, Colakoglu M, Colakoglu S, Sekuri C, Berdeli A. ACE I/D gene polymorphism and aerobic endurance development in response to training in a non-elite female cohort.  J Sports Med Phys Fitness. 2007;  47 234-238
• 5 Casajús JA. Seasonal variation in fitness variables in professional soccer players.  J Sports Med Phys Fitness. 2001;  41 463-469
• 6 Chang YF, Imam JS, Wilkinson MF. The nonsense-mediated decay RNA surveillance pathway.  Annu Rev Biochem. 2007;  76 51-74
• 7 Cometti G, Maffiuletti NA, Pousson M, Chatard JC, Maffulli N. Isokinetic strength and anaerobic power of elite, subelite and amateur French soccer players.  Int J Sports Med. 2001;  22 45-51
• 8 Day SH, Gohlke P, Dhamrait SS, Williams AG. No correlation between circulating ACE activity and VO₂max or mechanical efficiency in women.  Eur J Appl Physiol. 2007;  99 11-18
• 9 Ekblom B. Applied physiology of soccer.  Sports Med. 1986;  3 50-60
• 10 Ergün M, Işlegen C, Taşkiran E. A cross-sectional analysis of sagittal knee laxity and isokinetic muscle strength in soccer players.  Int J Sports Med. 2004;  25 594-598
• 11 Ferrell RE, Conte V, Lawrence EC, Roth SM, Hagberg JM, Hurley BF. Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes.  Genomics. 1999;  62 203-207
• 12 Fischer H, Esbjörnsson M, Sabina RL, Strömberg A, Peyrard-Janvid M, Norman B. AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects.  J Appl Physiol. 2007;  103 315-322
• 13 Giaccaglia V, Nicklas B, Kritchevsky S, Mychalecky J, Messier S, Bleecker E, Pahor M. Interaction between angiotensin converting enzyme insertion/deletion genotype and exercise training on knee extensor strength in older individuals.  Int J Sports Med. 2008;  29 40-44
• 14 Gonzalez-Freire M, Santiago S, Verde Z, Lao JI, Olivan J, Gómez-Gallego F, Lucia A. Unique among unique. Is it genetically determined?.  Br J Sports Med. , [in press, 2008]
• 15 Hunley TE, Julian BA, Phillips JA, Summar ML, Yoshida H, Horn RG, Brown NJ, Fogo A, Ichikawa I, Kon V. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.  Kidney Int. 1996;  49 571-577
• 16 Huygens W, Thomis MA, Peeters MW, Aerssens MW, Janssen R, Vlietinck RF, Beunen G. Linkage of myostatin pathway genes with knee strength in humans.  Physiol Genomics. 2004;  17 264-270
• 17 Jones A, Montgomery HE, Woods DR. Human performance: a role for the ACE genotype?.  Exerc Sport Sci Rev. 2002;  30 184-190
• 18 Jones A, Woods DR. Skeletal muscle RAS and exercise performance.  Int J Biochem Cell Biol. 2003;  35 855-866
• 19 Kirkendall DT. The applied sport science of soccer.  Physician Sportsmed. 1985;  13 53-59
• 20 Lazarim FL, Antunes-Neto JM, da Silva FO, Nunes LA, Bassini-Cameron A, Cameron LC, Alves AA, Brenzikofer R, de Macedo DV. The upper values of plasma creatine kinase of professional soccer players during the Brazilian National Championship.  J Sci Med Sport. 2008;  , [Epub ahead of print]
• 21 Little T, Williams AG. Specificity of acceleration, maximal speed, and agility in professional soccer players.  J Strength Cond Res. 2005;  19 76-78
• 22 Lowenstein JM. Ammonia production in muscle and other tissues: the purine nucleotide cycle.  Physiol Rev. 1972;  52 382-414
• 23 Lucia A, Gomez-Gallego F, Santiago C, Bandres F, Earnest C, Rabadan M, Alonso JM, Hoyos J, Cordova A, Villa G, Foster C. ACTN3 Genotype in professional endurance cyclists.  Int J Sports Med. 2006;  27 880-884
• 24 MacArthur DG, North KN. ACTN3: A genetic influence on muscle function and athletic performance.  Exerc Sport Sci Rev. 2007;  35 30-34
• 25 Matsakas A, Diel P. The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis.  Int J Sports Med. 2005;  26 83-89
• 26 Mills M, Tang R, Weinberger R, Vander Woude DL, Beggs AH, Easteal S, North K. Differential expression of the actin-binding proteins, α-actinin-2 and -3, in different species: implications for the evolution of functional redundancy.  Hum Mol Gen. 2001;  10 1335-1346
• 27 Mougios V. Reference intervals for serum creatine kinase in athletes.  Br J Sports Med. 2007;  41 674-678
• 28 Morisaki T, Gross M, Morisaki H, Pongrats D, Zöllinger N, Holmes EW. Molecular basis of AMP deaminase deficiency in skeletal muscle.  Proc Natl Acad Sci USA. 1992;  89 6457-6461
• 29 NCI-NHGRI Working Group on Replication in Association Studies (Chanock SJ, Manolio T, Boehnke M, et al.) . Replicating genotype-phenotype associations.  Nature. 2007;  447 655-660
• 30 Newman MA, Tarpenning KM, Marino FE. Relationships between isokinetic knee strength, single-sprint performance, and repeated-sprint ability in football players.  J Strength Cond Res. 2004;  18 867-872
• 31 Norman B, Glenmark B, Jansson E. Muscle AMP deaminase deficiency in 2% of healthy population.  Muscle Nerve. 1995;  18 239-241
• 32 Rankinen T, Wolfarth B, Simoneau J-A, Maier L-D, Rauramaa R, Rivera MA, Boulay MR, Chagnon YC, Pérusse L, Keul J, Bouchard C. No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status.  J Appl Physiol. 2000;  88 1571-1575
• 33 Reilly T, Thomas V. A motion analysis of work-rate in different positional roles in professional football match-play.  J Human Mov Stud. 1976;  2 87-97
• 34 Rico-Sanz J, Rankinen T, Joanisse DR, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C. Associations between cardiorespiratory responses to exercise and the C34 T AMPD1 gene polymorphism in the HERITAGE Family study.  Physiol Genomics. 2003;  14 161-166
• 35 Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.  J Clin Invest.. 1990;  86 1343-1346
• 36 Rubio JC, Martin MA, Rabadan M, San Juan AF, Alonso JM, Chicharro JL, Pérez M, Arenas J, Lucia A. Frequency of the C34 T mutation of the AMPD1 gene in World-class endurance athletes -does this mutation impair performance?.  J Appl Physiol. 2005;  98 2108-2112
• 37 Santiago C, González-Freire M, Serratosa L, Morate FJ, Meyer T, Gómez-Gallego F, Lucia A. ACTN3 genotype in professional soccer players.  Br J Sports Med. 2008;  42 71-73
• 38 Saunders MA, Good JM, Lawrence EC, Ferell RE, Li WH, Nachman MW. Human adaptive evolution at Myostatin (GDF8), a regulator of muscle growth.  Am J Hum Genet. 2006;  79 1089-1097
• 39 Seibert MJ, Xue QL, Fried LP, Walston JD. Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the Women's Health and Aging Study II cohort.  J Am Geriatr Soc. 2001;  49 1093-1096
• 40 Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJl. Myostatin mutation associated with gross muscle hypertrophy in a child.  N Engl J Med. 2004;  350 2682-2688
• 41 Shephard RJ. Biology and medicine of soccer: an update.  J Sports Sci. 1999;  17 757-786
• 42 Tarnopolsky MA, Parise G, Gibala MJ, Graham TE, Rush JW. Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans.  J Physiol. 2001;  533 881-889
• 43 Tumilty D. Physiological characteristics of elite soccer players.  Sports Med. 1993;  16 80-96
• 44 Williams AG, Rayson MP, Jubb M, World M, Woods DR, Hayward M, Martin J, Humphries SE, Montgomery HE. The ACE gene and muscle performance.  Nature. 2000;  403 614
• 45 Withers RT, Maricic Z, Wasilewski S, Kelly L. Match analyses of Australian professional soccer players.  J Human Mov Stud. 1982;  8 159-176
• 46 Yamin C, Amir O, Sagiv M, Attias E, Meckel Y, Eynon N, Sagiv M, Amir RE. ACE ID genotype affects blood creatine kinase response to eccentric exercise.  J Appl Physiol. 2007;  103 2057-2061
• 47 Yang N, MacArthur DG, Gulbin JP, Hahn AG, Beggs AH, Easteal S, North K. ACTN3 genotype is associated with human elite athletic performance.  Am J Hum Genet. 2003;  73 627-631

Correspondence